PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

37,801 stories, page 233 of 631

Advanced search
🇨🇦Researchnews.ubc.caTier 2 · Direct publisher

How we found Haida Gwaii’s first marbled murrelet nest in more than 30 years

University of British ColumbiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US Bishops launch pro-life campaign as pharmaceutical abortions on rise

Crux | Taking the Catholic PulseOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

India News

LatestLYOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What causes medicines shortages — the supply chain explained

The Pharmaceutical JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pune: FDA Suspends Licence of Hotel Chul Mutton in Lohegaon Over Food Safety Violations

lokmattimes.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trump takes credit for dropping pharmaceutical prices

Washington ExaminerOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical (NYSE:TAK) Shares Gap Up - Time to Buy?

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

HC Wainwright Has Lowered Expectations for BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price

MarketBeatOriginal source
🇮🇪CROiconplc.comTier 2 · Direct publisher

Regulatory trends in AI-enabled SaMDs

ICON plcOriginal source
🇺🇸Industryelementbiosciences.comTier 1 · Company source

Element Biosciences Appoints Global Biopharma R&D Leader Dr. Mikael Dolsten to Board of Directors

Element BiosciencesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Mumbai: FDA Suspends Licences of 3 Food Establishments Over Serious Safety and Hygiene Violations

lokmattimes.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Edgewise Therapeutics: Servier Deal Creates A Self-Funded Cardiovascular Platform (EWTX)

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

‘We Will Use Our Legal Option’: Maharashtra FDA Chief Tukaram Mundhe On Bombay HC’s ₹5 Lakh Order To Pune Sweets Shop

Republic WorldOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Oncolytics Biotech Aligns with FDA on Registrational Path for Pelareorep in RAS-Mutant Colorectal Cancer

OncodailyOriginal source
🇺🇸CROadvarra.comTier 2 · Direct publisher

Q&A with Advarra’s Senior Coordinator of Client Services Rachel Garrett

Advarra (IRB)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

CDSCO Panel Seeks Key Changes in Lupin's Phase III Trial of Biosimilar Insulin Degludec

Medical DialoguesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Oncolytics Biotech (ONCY) Advances Pelareorep Trial with Positive FDA Guidance

GuruFocusOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Reformed pharmaceutical regulation across India’s drug landscape

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles

tradingview.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China's GenScript Biotech H1 revenue rises on AI drug discovery

tradingview.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Argenx stock jumps after positive Phase 3 trial results for new autoimmune myositis treatment.

PluangOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Amylyx Pharmaceuticals Stock Soars 48% After Avexitide Hits All Endpoints in Pivotal Phase 3 Trial

International Business Times AustraliaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

We will use our legal option: Maharashtra FDA chief Tukaram Mundhe on Bombay HC order directing Rs 5 lakh payment to Pune-based sweets shop

ANI NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Vikram Anand on the "Hidden Gatekeeper" Behind Commercial Delays

pharmaceuticalcommerce.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

DARÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 Over 50: Innovation” List

markets.businessinsider.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioMarin to acquire Alesta Therapeutics

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Regeneron ends eye disease study due to antibody’s safety profile

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Wall Street Analysts Think Takeda Pharmaceutical Co. (TAK) Could Surge 26.41%: Read This Before Placing a Bet

finance.yahoo.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Substances Generally Recognized as Safe Proposed Rule

Office of Advocacy (.gov)Original source
🌍Industryorchestrabiomed.comTier 1 · Company source

Q2 2026 Progress Brings Key Pivotal Milestones Into View

Orchestra BioMedOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Amylyx Shares Jump 45% Following Positive Phase 3 Trial Results for GLP-1 Blocker Avexitide

TipRanksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Global $35+ Billion Pharmaceutical Electronic Manufacturing Services (EMS) Market Outlook, 2031

finance.yahoo.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Analysts Offer Insights on Healthcare Companies: OmniAb (OABI), Neurocrine (NBIX) and Evaxion Biotech (EVAX)

The Globe and MailOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PhenoNet gets FDA green light for Phase 3 Alzheimer’s trial

Indian Pharma PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AC Immune’s Parkinson’s drug candidate Wins FDA Fast Track designation

Indian Pharma PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How waste feedstocks and biotech create circular cosmetic ingredients

Personal Care InsightsOriginal source
🌍Mediaskpharmteco.comTier 3 · Secondary coverage

SK pharmteco Marks Construction Progress with Ribbon Cutting for Two Advanced Manufacturing Facilities at Swords, Ireland Campus

SkpharmtecoOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why is BioMarin Pharmaceutical stock surging today?

Investing.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Longevica Therapeutics Appoints Ex-Genentech Biotech Veteran Dr. Prasun Mishra as CEO to Advance World's Largest $13 Million Mammalian Longevity Study Toward Clinical Development

biospace.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nashik: Safe, Nutritious Food Mandatory In ZP Schools; CEO Omkar Pawar Orders Strict Compliance

Free Press JournalOriginal source
🌍discoverynews.google.comTier 2 · Trade media

BioMarin bulks up bone unit with $275M Alesta buyout to challenge AstraZeneca

fiercebiotech.comOriginal source
🇺🇸CROmedidata.comTier 2 · Direct publisher

The Impact of AI in Healthcare: What Are the Real-world Effects?

Medidata SolutionsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioMarin Pharmaceutical to Acquire Alesta Therapeutics for up to $490 Million

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Oncolytics may seek accelerated approval using tumor response data

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioMarin to acquire Alesta for $275M upfront (BMRN:NASDAQ)

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

OmniAb: Lilly-Style Partners Paying Attention To This Early-Stage Biotech (NASDAQ:OABI)

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers

PharmTech.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Rebounding biotech funds expected to spur CDMO growth within year

BioSpaceOriginal source
🇩🇪Researchuni-heidelberg.deTier 2 · Direct publisher

Universität Heidelberg Achieves Top Placements in Shanghai Ranking

Heidelberg UniversityOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lipitor Lawsuit 2026: Payouts, Settlements, Claims

LawFold.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ACMA’s Data Provides: The Critical Data Layer Pharmaceutical Companies Need Now More Than Ever

manilatimes.netOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Amylyx (AMLX) Stock Surges Past 52-Week High on Successful Avexitide Phase 3 Results

BlockonomiOriginal source
🌍Regulatorynafdac.gov.ngTier 1 · Regulatory source

Public Alert No: 039/2026 – Alert on the Risk of Drug Poisoning Associated with Concurrent Use of Gabapentinoids and Other Medicines

NAFDAC NigeriaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The 82x ROI Claim Every Oncology Sponsor Is About to Misread

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Breakthrough NAD Formula Propels Wonderfeel to No. 1 Fastest-Growing Biotech Company and No. 65 Overall on the 2026 Inc. 5000

PR NewswireOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Unauthorized drugs seized from Rabais 4Saisons Inc. in Montreal, QC, may pose serious health risks

Health Canada has seized several unauthorized drugs (including an oral emergency contraceptive drug,...

Health Canada Recalls and Safety AlertsOriginal source
🌍Researchpremier-research.comTier 2 · Direct publisher

Regulatory Operations: The Overlooked Half of Submission Readiness

Premier ResearchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation

lincolnjournal.comOriginal source